Supreme Senior One

Supreme Senior One

Since everyone dreams to live a prosperous and financially free life, financial services that are helpful in making this dream true, are getting high heed by consumers. Purchase of life insurance policy is one of those financial activities that are helping people in securing their future financial requirements. These life insurance policies are helping people in making their old age hassle free to some extent but when it comes to arranging urgent finance for any emergency requirement, these policies fail to provide premature financial benefits to the policyholder. However, these policies carry supreme financial benefits but, as these benefits can be availed only after a cretin time period, a senior citizen may find his or her existing policy burdensome.

To solve this problem, insurance companies offer life settlement facility, so that the senior policy holders may get an opportunity to sell their immature policy to arrange money for meeting their requirements. As far as profitability of life settlement procedure is concerned, the policyholder gets maximum amount from the sale of his or her policy. Life settlement procedures that are protected by bonding company are known as bonded life settlement procedures. This kind of life settlement procedure is safe and highly beneficial for both the parties.

Bonded life settlement is opening a secondary market for unwanted life insurance policies, as this procedure allows the investor to become new owner of the entrusted policy. This not only circulates a policy for a long time but also generates more profit for insurance companies. In fact, bonded life settlement is highly beneficial for every party that is involved in this policy circulation process. There are people, who think that selling an existing life insurance policy may decrease their financial benefits but in reality, it provides the policyholder with instant and reasonable financial benefits.

Basically, bonded life insurance policies are those insurance polices that have been underwritten as per the standards of the bonding company. This kind of sale and purchase of policy carries lower return on investments, as the investor pays the remaining premium amount after settlement. However, it is for sure that the policyholder gets maximum amount on the basis of face value of his or her policy. The insurance company plays a vital role in bonded life settlement therefore, the policyholder can be rest assured about authenticity and security of that procedure.

Bonded life settlement is an unbeatable tool for seniors to sell off an existing policy that is no more needed. This kind of life settlement procedure offers maximum financial benefit on the investment of the policyholder. For all senior policy holders, who possess a bonded life insurance policy, this life settlement procedure is a considerable option, as it can sell off their unwanted life insurance policy in an highly profitable manner. An investor can purchase bonded life insurance polices through a bonded life settlement company, as only such companies are authorized to conduct life settlement procedures. In fact, this is a highly beneficial scheme for both the policy holder and investor, as it provides them with supreme financial benefits.

William Regal is an expert in dealing with life settlement. If you have any queries about life settlement,life settlement broker,life settlement investment, Bonded life settlement [http://www.mylifesettlementbroker.com/bonded-life-settlement.php], visit: http://www.mylifesettlementbroker.com

Citizens Win Huge Supreme Court Victory Over Big Pharma And The Fda

In a stunning and unexpected 6-3 ruling the right-leaning Supreme Court went against the wishes of the last president, took the wind out of the sails of health care reform of the current president, sent irresponsible Big Pharma a major wake up call, and bluntly told the arrogant FDA that they are indeed not above the rule of law. It is a major victory for every American citizen.

Central to the issue is a power a struggle between the federal government and states, which in this situation meant the federal government authority to pre-empt your state rights to sue if you are injured by a drug. The FDA, acting on behalf of the Bush administration and on the side of Big Pharma, has helped tie up thousands of drug injury lawsuits across the country. The FDA, who is supposed to be protecting consumers from drug injury and ensuring a correct risk/safety picture for any person taking a drug, was instead trying to shirk their responsibility and simply claim that Americans had no right to sue.

This convoluted attempt by the FDA to undermine consumer safety was one of the main themes in my 2006 book, Fight for Your Health: Exposing the FDA's Betrayal of America. The Bush Administration had intentionally appointed anti-safety people in high positions within the FDA, starting with its Chief Counsel, Daniel Troy (and continued as a legal philosophy after Troy was forced out for his Big Pharma connections). Troy set in motion the legal problem the Supreme Court just decided.

During the final years of the Bush administration cancer industry insider Andrew von Eschenbach, MD, was appointed to run the FDA, and Wall Street insider, Scott Gottlieb, MD, was second in command. These individuals sought to fully implement the FDA label as senior to any rights of citizens. Their intention was to make sure that new biotech drugs would be protected from lawsuits, as the FDA wanted to speed new and even more dangerous drugs onto the market so as to foster the development of the biotech industry. In essence, the FDA management wanted to turn the American public into one large clinical experiment, with no right of recourse when injured.

This was occurring against a backdrop wherein the FDA couldn't even name all the drugs currently on the market, had failed to demand required aftermarket follow up safety testing on drugs, and had intentionally withheld safety information on existing drugs from the public. The current situation with drugs is that almost no drug, even blockbusters and those in use for decades, have an accurate risk/benefit profile.

Americans who use medications are already taking risks of unknown magnitude, which is a main reason over 100,000 Americans are killed every year and over 3 million are injured so seriously they need hospital care (ironically, over half those injuries occur while already in the hospital).

The FDA knows full well that when a drug is approved for the market the full extent of the side effects won't be known for years. History shows us time and again that Big Pharma actively hides risk data from the FDA and pays for "science" that distorts reality. This irresponsible behavior goes along with closed-door negotiations with the FDA, and has resulted in numerous drug disasters like Vioxx. FDA managers oftentimes go against the wishes of their own safety scientists and then move on to six figure salaries in the industry they regulate. Doctors are not apprised of the actual risks and consumers are in the dark.

Currently, there are 450,000 additional new cases of heart failure every year in Americans over 65, a fact that parallels the increased use of heart-weakening statins in this older group. It is only a matter of time before the shoe drops on the 20-billion-dollar-a-year statin industry.

The FDA insistence that a drug label, based on what is known at the time of approval, should supersede citizen's states rights to sue if they were injured, has almost nothing to do with consumer safety. Rather, it is a federal power grab that is in the best financial interests of Big Pharma and Big Biotech, industries that do not have consumer safety as their top priority.

By the way, don't think President Obama is on the side of the citizens. In the health care section of the stimulus bill, there is specific pre-emption language. If the federal government is in charge of health care it will be named in future lawsuits when patients are injured from the care it doles out or doesn't allow.

The current Supreme Court ruling will undermine any system of federal health care wherein the drugs being used are injuring people. Experts believe this system is so badly broken, due to gross FDA management incompetence, that it will take 10 years of studies and many billions of dollars just to understand the actual risks of the drugs Americans are already taking.

In writing for the majority, Justice John Paul Stevens put Big Pharma on notice. The defendant in this case, Wyeth, had argued that it could not comply with both federal and state law. Stevens told them they had a fundamental misunderstanding of regulation and were trying to hide behind the FDA, going on to say that it is a central premise of federal drug regulation that the manufacturer bears responsibility for the content of its label at all times. That is not the news Big Pharma wanted to hear.

Stevens went on to write that there was no merit in the argument that the FDA's labeling decisions could supersede state law, saying that this argument was "an untenable interpretation of congressional intent and an overbroad view of an agency's power to pre-empt state law." He pointed out that the FDA tried to push this on the public without any opportunity for comment from the public or from states, all done against a backdrop wherein the FDA is not able to keep up with safety issues in the first place, meaning that the FDA position lacked "thoroughness, consistency and persuasiveness." Stevens stated that under such lacking standards the Bush position "is entitled to no weight."

This is a major victory for all Americans and for states. While the case itself is on the topic of Big Pharma and the FDA, the ruling is sweeping in nature and will extend far beyond prescription drugs. States have just been handed a major legal ruling against the ever-growing incursion of federal power.

About the Author

Byron J. Richards, Founder/Director of Wellness Resources, Inc., is a Board-Certified Clinical Nutritionist and a world renowned natural health expert. Richards is the first to explain the relevance of leptin and its link to solving obesity.